Which hedge funds own GILD? GILEAD SCIENCES INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
14 of the hedge funds tracked by WhaleCreep disclosed a position in GILD (GILEAD SCIENCES INC) in their Q2 2026 13F filings, worth $2.0bn in total. The largest holder by portfolio weight is Holocene Advisors at 0.9% of its book.
14tracked managers holding
0opened this quarter
0exited this quarter
Which hedge funds hold GILD? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Holocene Advisors | Q2 2026 | 0.9% | $406.4m | 3,216,892 | 23% | added |
| Avidity Partners | Q2 2026 | 0.4% | $2.5m | 20,000 | 0% | held |
| Renaissance Technologies LLC | Q2 2026 | 0.4% | $280.1m | 2,217,376 | 3% | added |
| Point72 Asset Management LP | Q2 2026 | 0.3% | $181.6m | 1,437,685 | 16222% | added |
| Citadel Advisors | Q2 2026 | 0.3% | $439.7m | 3,480,444 | -13% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.2% | $15.6m | 123,329 | 214% | added |
| Woodline Partners | Q2 2026 | 0.2% | $66.8m | 528,600 | 6% | added |
| D. E. Shaw & Co | Q2 2026 | 0.2% | $289.9m | 2,294,789 | 1042% | added |
| Ancora Advisors | Q2 2026 | 0.2% | $8.0m | 121,465 | -7% | reduced |
| Bridgewater Associates | Q2 2026 | 0.2% | $36.7m | 290,881 | 61% | added |
| Millennium Management | Q2 2026 | 0.1% | $184.3m | 1,458,924 | 24% | added |
| Tudor Investment | Q2 2026 | 0.0% | $9.5m | 74,896 | 28% | added |
| First Manhattan | Q2 2026 | 0.0% | $8.9m | 70,366 | -6% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $25.9m | 204,677 | -91% | reduced |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Boston Omaha | Q4 2024 | 0.1% |
| Caxton Associates | Q4 2024 | 0.0% |
How has hedge fund ownership of GILD changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 14 | $2.0bn |
| Q1 2026 | 14 | $1.9bn |
| Q4 2025 | 6 | $957.3m |
| Q3 2025 | 7 | $1.0bn |
| Q2 2025 | 8 | $1.3bn |
| Q1 2025 | 8 | $1.1bn |
| Q4 2024 | 9 | $707.1m |
| Q3 2024 | 8 | $734.5m |
| Q2 2024 | 10 | $570.5m |
| Q1 2024 | 10 | $526.8m |
| Q4 2023 | 9 | $652.3m |
| Q3 2023 | 10 | $603.6m |
| Q2 2023 | 10 | $722.2m |
| Q1 2023 | 9 | $975.3m |
| Q4 2022 | 9 | $933.3m |
| Q3 2022 | 9 | $862.5m |
Counts every tracked manager that disclosed GILD in that quarter's filing, including managers that have since stopped filing.